Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.

about

Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells.

P2860

Q47694726-FE0478F8-8799-41C8-96A8-07751D6BBF94

P2860

Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q38769960

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prognostic and biological sign ...... FL7 in acute myeloid leukemia.

@en

type

Item

label

Prognostic and biological sign ...... FL7 in acute myeloid leukemia.

@en

prefLabel

Prognostic and biological sign ...... FL7 in acute myeloid leukemia.

@en

P1476

Prognostic and biological sign ...... FL7 in acute myeloid leukemia.

@en

P2093

Adrienne M Dorrance

http://www.w3.org/2001/XMLSchema#string

Bayard L Powell

http://www.w3.org/2001/XMLSchema#string

Betina McNeil

http://www.w3.org/2001/XMLSchema#string

Changxian Shen

http://www.w3.org/2001/XMLSchema#string

Christopher C Oakes

http://www.w3.org/2001/XMLSchema#string

Damian J Steiner

http://www.w3.org/2001/XMLSchema#string

Deedra Nicolet

http://www.w3.org/2001/XMLSchema#string

Dimitrios Papaioannou

http://www.w3.org/2001/XMLSchema#string

Eunice S Wang

http://www.w3.org/2001/XMLSchema#string

Gregory K Behbehani

http://www.w3.org/2001/XMLSchema#string

P2860

Adhesion of human platelets to serum amyloid A

GENCODE: the reference human genome annotation for The ENCODE Project

Nonparametric Estimation from Incomplete Observations

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.

FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.

Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.

P304

E4641-E4647

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1703142114

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28533390

http://www.w3.org/2001/XMLSchema#string

P932

5468639

http://www.w3.org/2001/XMLSchema#string

Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.

about

P2860

P2860

Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932